More Kwality Pharmaceuticals Ltd news
Kwality Pharmaceuticals LtdBSE: KPL

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Nov 9, 2026 at 3:00 AM EST · Issued by Kwality Pharmaceuticals Ltd via BSE India

Filed with BSE · ISIN INE552U01010 · Nov 9, 2026 at 3:00 AM EST · 2 pages · English

On 6ix: 6ix.com/news/announcement-under-regulation-30-lodr-analyst-investor-meet-intimation-287

Kwality Pharmaceuticals Ltd on 6ix

In the deck

  • Kwality Pharmaceuticals — H1 FY27 Earnings Presentation41 slidesNov 12, 2026

Story so far

  • Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2026.Nov 5, 2026

Earlier from Kwality Pharmaceuticals

  • Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2026.Nov 5
  • EU-GMP Approval From Hungary For Cephalosporin And Oncology FacilitiesNov 4
  • Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 10
  • Kwality Pharmaceuticals Ltd Press Release Sep 28 2026Sep 28
  • Kwality Pharmaceuticals Ltd Press Release Aug 31 2026Aug 31

Later from Kwality Pharmaceuticals

  • Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 16
All Kwality Pharmaceuticals news releases↗

Follow Kwality Pharmaceuticals into a list and get an email when it puts out news.

Follow Kwality Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer